You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 21, 2025

Ge Hlthcare Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Ge Hlthcare
International Patents:99
US Patents:6
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Ge Hlthcare

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Ge Hlthcare FLYRCADO flurpiridaz f-18 SOLUTION;INTRAVENOUS 215168-001 Sep 27, 2024 RX Yes Yes 9,603,951 ⤷  Try for Free ⤷  Try for Free
Ge Hlthcare FLYRCADO flurpiridaz f-18 SOLUTION;INTRAVENOUS 215168-001 Sep 27, 2024 RX Yes Yes 8,936,777 ⤷  Try for Free ⤷  Try for Free
Ge Hlthcare FLYRCADO flurpiridaz f-18 SOLUTION;INTRAVENOUS 215168-001 Sep 27, 2024 RX Yes Yes 8,226,929 ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 3 of 3 entries

Supplementary Protection Certificates for Ge Hlthcare Drugs

Patent NumberSupplementary Protection CertificateSPC CountrySPC ExpirationSPC Description
0703791 9/2003 Austria ⤷  Try for Free PRODUCT NAME: IOFLUPANE (123I); REGISTRATION NO/DATE: EU/1/00/135/001 20000727
0703791 C300123 Netherlands ⤷  Try for Free PRODUCT NAME: IOFLUPANE (123I); NAT. REGISTRATION NO/DATE: EU/1/00/135/001 20000727; FIRST REGISTRATION: EU/1/00/135/001 20000727
0703791 SPC/GB03/010 United Kingdom ⤷  Try for Free PRODUCT NAME: IOFLUPANE (123I) OR (123I)-2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)-8-(3-FLUOROPROPYL)-NORTROPANE; REGISTERED: UK EU/1/00/135/001 20000802
>Patent Number>Supplementary Protection Certificate>SPC Country>SPC Expiration>SPC Description
Showing 1 to 3 of 3 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pharmaceutical Competitive Landscape Analysis: GE Healthcare – Market Position, Strengths & Strategic Insights

In the ever-evolving world of healthcare technology, GE Healthcare stands as a formidable player, constantly pushing the boundaries of innovation and market dominance. As we delve into the pharmaceutical competitive landscape, we'll explore how GE Healthcare positions itself, leveraging its strengths and strategic insights to maintain its edge in this fiercely competitive industry.

GE Healthcare's Market Position

GE Healthcare has established itself as a global leader in the healthcare technology sector, with a strong presence in over 100 countries. The company's market position is characterized by its commitment to innovation, diverse product portfolio, and global reach.

Global Presence and Market Share

GE Healthcare's extensive global footprint allows it to serve a wide range of customers and adapt to local market dynamics. This global presence has contributed significantly to its market share, which spans across various healthcare segments.

"GE Healthcare delivered strong revenue growth in the fourth quarter and full year 2022, driven by robust end-market demand, improved pricing, and easing supply chain pressures," GE HealthCare President and CEO Peter Arduini said[4].

Product Portfolio Diversity

One of the key factors contributing to GE Healthcare's strong market position is its diverse product portfolio. The company offers a wide range of medical technologies and services, including:

  1. Diagnostic imaging systems
  2. Patient monitoring devices
  3. Healthcare IT solutions
  4. Pharmaceutical diagnostics

This comprehensive range of offerings allows GE Healthcare to cater to various aspects of healthcare delivery and research, solidifying its position in the market.

Competitive Advantages of GE Healthcare

GE Healthcare's competitive edge stems from several key factors that set it apart in the pharmaceutical and healthcare technology landscape.

Technological Innovation and R&D Focus

At the heart of GE Healthcare's competitive advantage lies its unwavering commitment to innovation and research. The company invests heavily in R&D to develop cutting-edge technologies that address the evolving needs of healthcare providers and patients.

Strong Brand Reputation

GE Healthcare has built a strong brand reputation over the years, known for its quality products, reliability, and commitment to innovation. This positive brand image gives the company a significant competitive edge in the market.

Customer-Centric Approach

GE Healthcare places a strong emphasis on understanding and meeting the needs of its customers. The company works closely with healthcare providers and researchers to develop tailored solutions that address specific challenges and deliver value.

"I'm incredibly proud of the work our team has done to complete the spin-off of GE HealthCare," Arduini said. "The energy across the company is palpable and there is tremendous excitement and focus around our purpose to create a world where healthcare has no limits."[4]

Strategic Insights: GE Healthcare's Growth Strategy

GE Healthcare's growth strategy is multifaceted, focusing on several key areas to maintain its competitive edge and drive future success.

Investing in Innovation

GE Healthcare continues to invest heavily in research and development, with a focus on developing new products and technologies that address the evolving needs of the healthcare industry. In 2023, the company invested over $1 billion in R&D and launched more than 40 new products[7].

Expanding in Emerging Markets

The company is actively pursuing growth opportunities in emerging markets, where there is increasing demand for advanced healthcare technologies and services.

Focus on Precision Health

GE Healthcare is placing a strong emphasis on precision health, developing technologies and solutions that enable personalized and targeted healthcare delivery.

Strategic Acquisitions and Partnerships

To enhance its product portfolio and expand its market reach, GE Healthcare engages in strategic acquisitions and partnerships. For example, the acquisition of MIM Software has strengthened its position in the AI and digital solutions space[8].

GE Healthcare's Financial Performance

GE Healthcare's financial performance provides valuable insights into its market position and competitive strength.

Revenue Growth

In 2023, GE Healthcare reported total revenues of $19.6 billion, representing a 7% increase year-over-year and an 8% increase on an organic basis[10].

Profitability

The company's net income attributable to GE Healthcare was $1.6 billion in 2023, with an Adjusted EBIT of $3.0 billion[10].

Order Book and Future Outlook

GE Healthcare's total company book-to-bill ratio was 1.03 times in 2023, indicating strong future revenue potential. The company's orders increased by 3% organically year-over-year[10].

Challenges and Opportunities in the Pharmaceutical Landscape

While GE Healthcare enjoys a strong market position, it also faces several challenges and opportunities in the pharmaceutical and healthcare technology landscape.

Challenges

  1. Intense competition from other major players like Siemens Healthineers and Philips Healthcare
  2. Regulatory challenges and compliance requirements
  3. Rapid technological advancements requiring continuous innovation

Opportunities

  1. Growing demand for healthcare services worldwide
  2. Increasing focus on personalized medicine and precision health
  3. Expansion opportunities in emerging markets

GE Healthcare's Competitive Strategy

To maintain its competitive edge, GE Healthcare employs a multifaceted strategy that leverages its strengths and addresses potential weaknesses.

Continuous Innovation

GE Healthcare maintains its focus on innovation, consistently introducing new products and technologies to stay ahead of the competition.

Strategic Partnerships

The company forms strategic partnerships with healthcare providers, research institutions, and industry stakeholders to leverage expertise and drive innovation.

Customer-Centric Solutions

GE Healthcare continues to prioritize customer needs, developing tailored solutions that address specific challenges in healthcare delivery and research.

Future Prospects and Market Outlook

Looking ahead, GE Healthcare's future prospects appear promising, driven by several key factors:

  1. Increasing global healthcare spending
  2. Growing demand for advanced medical technologies
  3. Focus on precision health and personalized medicine
  4. Expansion opportunities in emerging markets

However, the company will need to navigate challenges such as intense competition and regulatory pressures to maintain its market position and drive future growth.

Key Takeaways

  1. GE Healthcare maintains a strong market position through its diverse product portfolio, global presence, and focus on innovation.
  2. The company's competitive advantages include technological innovation, strong brand reputation, and a customer-centric approach.
  3. GE Healthcare's growth strategy focuses on investing in R&D, expanding in emerging markets, and pursuing strategic acquisitions and partnerships.
  4. The company's financial performance shows steady growth, with revenues of $19.6 billion in 2023 and a positive outlook for future orders.
  5. While facing challenges such as intense competition and regulatory pressures, GE Healthcare is well-positioned to capitalize on opportunities in the growing healthcare technology market.

FAQs

  1. What is GE Healthcare's market share in the healthcare technology industry? While exact market share figures vary by segment, GE Healthcare is a leading player in several areas, including diagnostic imaging and healthcare IT solutions.

  2. How does GE Healthcare's R&D investment compare to its competitors? GE Healthcare invested over $1 billion in R&D in 2023, demonstrating a strong commitment to innovation compared to industry peers.

  3. What are GE Healthcare's key growth markets? While GE Healthcare operates globally, emerging markets present significant growth opportunities due to increasing healthcare spending and demand for advanced technologies.

  4. How is GE Healthcare addressing the trend towards personalized medicine? GE Healthcare is focusing on precision health, developing technologies and solutions that enable more personalized and targeted healthcare delivery.

  5. What impact has the spin-off from General Electric had on GE Healthcare's performance? Since its spin-off in early 2023, GE Healthcare has shown strong performance as an independent company, with solid revenue growth and a focus on innovation and strategic growth initiatives.

Sources cited: [1] https://investor.gehealthcare.com/static-files/c43bf892-a59f-437b-b448-f9b2f178ef5b [2] https://canvasbusinessmodel.com/blogs/competitors/ge-healthcare-competitive-landscape [4] https://www.gehealthcare.com/insights/article/q4-%E2%80%9922-results-strong-revenue-growth-and-an-exciting-first-year-ahead-as-a-standalone-company [5] https://canvasbusinessmodel.com/blogs/growth-strategy/ge-healthcare-growth-strategy [7] https://www.fiercebiotech.com/medtech/ge-healthcare-plots-theranostics-growth-it-beats-earnings-estimates-first-independent-year [8] https://www.gurufocus.com/news/2574923/decoding-ge-healthcare-technologies-inc-gehc-a-strategic-swot-insight [10] https://investor.gehealthcare.com/news-releases/news-release-details/ge-healthcare-reports-fourth-quarter-and-full-year-2023

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.